If you're wondering whether maca root is a legitimate fix for low energy or flagging libido, the honest answer is: it can help, but only in specific use cases, and it does not work the way most supplement marketing suggests. This article breaks down the human trial data for Lepidium meyenii, explains why the three maca color varieties are not interchangeable, and examines the two most consistent findings in the RCT record — SSRI-induced sexual dysfunction and modest energy effects in Peruvian cohorts. You'll also get a clear account of why maca does not work by changing your testosterone or estrogen levels, which products are worth considering, and where the real interaction risks sit for this supplement.
Summary: quick answer on maca for energy and libido
Maca has the most consistent human trial evidence for reducing SSRI-induced sexual dysfunction, a more modest and inconsistently replicated signal for energy and libido in healthy adults, and no meaningful effect on circulating sex hormones in most trials.
Best for: Adults experiencing sexual side effects from SSRI antidepressants who have discussed the option with their prescriber. Adults with unexplained fatigue who have addressed obvious contributors (sleep, iron, thyroid) and want a well-tolerated low-risk supplement. People interested in red maca specifically for prostate-related outcomes (early but consistent data from Gonzales lab research).
Not ideal for: Anyone expecting measurable testosterone or estrogen changes from maca — the trial record does not support this. People with hypothyroidism on levothyroxine who consume raw maca frequently (goitrogen concern, largely mitigated with gelatinized or cooked forms). Anyone whose primary goal is a libido boost driven by identifiable hormonal deficiency — that needs diagnosis and prescriber involvement, not maca.
Decision shortcut: Maca is not a hormone supplement. It is a root vegetable from the Andes with a modest but real track record in two narrow use cases. If your situation falls outside those, the evidence does not support expecting much.
What you'll find in this guide
- What maca actually is and where it comes from
- Yellow, red, and black: why color variety matters
- What the human trials actually show
- The SSRI connection: the strongest evidence in the record
- Who benefits and who should skip it
- Dosing ranges from the clinical trials
- Side effects and drug interactions
- Product picks
- Frequently asked questions
What maca actually is and where it comes from {#what-maca-is}
Lepidium meyenii is a Peruvian crucifer — a member of the same botanical family as broccoli, kale, and cabbage. It grows in the Andes at altitudes of 4,000 to 4,500 meters, in thin, cold air with volcanic soil and intense UV exposure. The edible part is the hypocotyl, a fleshy, turnip-like underground stem that is dried, powdered, or gelatinized for supplement use.
In the Andean highlands, maca has been a food staple for thousands of years, traditionally associated with fertility and stamina. But traditional use is not the same as RCT evidence, and the two records do not always agree on what maca actually does.
The bioactive components of most interest in pharmacological research are macamides, fatty acid amides unique to the species that are structurally related to endocannabinoids. Early preclinical work suggests macamides may act on the endocannabinoid system, potentially explaining energy and mood effects without obvious hormonal pathways. The glucosinolates in maca are the same class of compounds found in broccoli, and at high doses can have goitrogen effects on the thyroid.
The key pharmacological point: despite marketing calling maca a "natural hormone balancer," the human trial evidence shows it does not meaningfully raise or lower testosterone, LH, FSH, or estradiol. It appears to exert its effects parallel to — not through — the classical hormonal axis. Understanding this prevents the most common maca misconception.
Think of it like soil and a plant. Hormonal therapies are direct watering — measurable, traceable delivery. Maca, if it does anything, seems to improve soil conditions without being the water. The benefit is indirect and depends heavily on the starting state.
Yellow, red, and black: why color variety matters {#color-varieties}
Maca is sold in three color varieties — yellow, red, and black — and supplement brands frequently blur distinctions between them. The color difference is not cosmetic. The varieties have different glucosinolate and anthocyanin profiles, and the limited human and animal research available suggests genuinely different tissue-level effects.
Yellow maca is the most common commercially available form and the variety used in the majority of human energy and libido trials. When an RCT describes "maca," it usually means yellow or unspecified mixed maca powder. This is the baseline.
Red maca has attracted attention for prostate-related outcomes in men and bone density in women with estrogen deficiency. Animal studies from the Gonzales lab in Lima demonstrated that red maca — but not yellow or black — reduced prostate size in testosterone-stimulated rats. Robust human RCT data for either outcome remain limited.
Black maca is the least common variety, studied primarily for sperm motility and cognition. Animal work from the same Peruvian research group showed black maca outperforming yellow and red on sperm count and swimming speed. A small crossover pilot in healthy men found an association with improved verbal recall, but the study was not blinded and the sample was very small.
The honest read on color specificity: The color-variant data is real, but most of it comes from animal studies or very small human pilots. Any retailer claiming that their specific color variety will "target" a specific outcome for you is outrunning the available evidence considerably.
Actionable takeaway: If you're buying maca for the published human RCTs on sexual function and energy, yellow maca or a mixed maca product matches what those trials used. If you're interested in red maca for prostate health, the animal signal is consistent enough to be worth mentioning — but tell your urologist.
What the human trials actually show {#what-research-shows}
The human trial record for maca is small but not absent. Most trials are Peruvian, single-center, with modest sample sizes. Effect sizes are generally modest. Here is the strongest evidence:
Energy and subjective wellbeing in healthy adults
Gonzales et al., 2002 (PMID 12181987) conducted one of the earliest placebo-controlled trials of maca in men aged 21 to 56 years (n=57) over 12 weeks. Participants received 1,500mg or 3,000mg of dried maca root or placebo. Serum testosterone and estradiol did not differ significantly between groups at any time point. Subjective sexual desire (using an unvalidated questionnaire) increased at 8 weeks in the maca groups but not placebo. This is widely cited as the foundational libido trial, but the outcome measure was non-validated and the trial was not powered for hard outcomes like morning testosterone or validated sexual function instruments.
Stone et al., 2009 (PMID 19781622) randomized fourteen cyclists (mixed sex) to maca extract or placebo for 14 days before a cycling time trial. Maca supplementation was associated with improved 40km time trial performance and self-reported sexual desire scores compared to placebo. This trial is small (n=14), which limits interpretation substantially, but it is one of the few that simultaneously captured both an energy-adjacent outcome (cycling performance) and a libido-adjacent outcome in the same cohort.
Brooks et al., 2008 (PMID 18813112) studied the effects of maca on sexual dysfunction and psychological symptoms in healthy postmenopausal women (n=14) in a double-blind crossover design. Maca supplementation (3.5g/day) for 6 weeks was associated with statistically significant reductions in psychological symptom scores (including anxiety and depression subscales) and improvements in sexual dysfunction scores compared to placebo. Hormone levels (estradiol, FSH) did not change, again reinforcing the pattern that maca's effect, where present, does not route through estrogen.
The real question with the healthy-adult trials is not whether maca works in lab rats — it's whether the human dose proves out. Most of these trials are underpowered, single-center, and rely on non-validated subjective scales. An appropriate read of this literature is "plausible modest benefit in some adults, evidence insufficiently sized to be confident." That is not the same as "no evidence" — but it is very far from "proven."
Actionable takeaway: In healthy adults, the energy and libido signal from maca is real but small and inconsistently replicated across trials. Hormone levels don't change. Subjective wellbeing and desire scores sometimes improve. If you're hoping for a dramatic effect, the trial data doesn't support that expectation.
The SSRI connection: the most consistent evidence in the record {#ssri-evidence}
The strongest human trial data for maca sits in a specific and underappreciated use case: sexual dysfunction caused by SSRI antidepressants.
SSRIs commonly cause sexual side effects — reduced desire, delayed orgasm, anorgasmia — in a substantial proportion of users, often distressing enough to drive medication non-adherence.
Dording et al., 2008 (PMID 18096708) conducted a double-blind dose-finding study comparing 3g/day versus 1.5g/day maca root in 20 adults on SSRIs with SSRI-induced sexual dysfunction. Both doses produced improvements on validated sexual function scales, with the 3g dose producing significantly more improvement. Well-controlled for a pilot, with validated outcome instruments.
Dording et al., 2015 (PMID 25278172) followed with a placebo-controlled RCT of 3g/day maca versus placebo in adults with SSRI-induced sexual dysfunction (n=45, 67% female). Maca produced significantly greater improvement in libido and sexual function scores at 12 weeks. Hormone levels were unchanged. This is the cleanest RCT in the maca literature: pre-specified primary endpoint, validated instrument, blinded.
Neither Dording trial is adequately powered to be definitive — n=20 and n=45 are preliminary positive results, not settled evidence. But relative to the rest of the maca record, they are methodologically the strongest. Why maca helps SSRI-induced sexual dysfunction without changing hormones is not fully understood; macamides' potential dopaminergic effects have been proposed but remain preclinical-level speculation.
Actionable takeaway: If you are experiencing SSRI-induced sexual dysfunction and want to discuss a supplement option with your prescriber, the Dording 2015 RCT is worth sharing. This is the use case where the maca literature is most coherent. That said, your prescriber may also have prescribing options (bupropion, dose adjustment, switching agents) that have larger effect sizes and more evidence. Maca is a plausible adjunct, not a replacement for that conversation.
Who benefits and who should skip it {#who-its-for}
Strong fit: Adults with SSRI-induced sexual dysfunction who want to try an adjunct supplement with evidence behind it, and who have discussed it with their prescriber. Adults with unexplained fatigue who have ruled out the treatable causes (sleep apnea, iron deficiency, hypothyroidism, vitamin D deficiency) and want a safe, well-tolerated supplement to trial. Men with prostate health concerns who want to explore red maca alongside conventional monitoring.
Skip if: You are on levothyroxine or any thyroid medication. Raw maca's glucosinolates can suppress thyroid function in predisposed individuals. Gelatinized maca reduces this risk substantially, but discussing it with your prescriber first is still appropriate. People expecting measurable testosterone gains should look elsewhere — the trial record is consistent that maca does not raise testosterone.
Special population: Postmenopausal women. The Brooks 2008 trial and some smaller Peruvian studies suggest maca may have a favorable effect on psychological and sexual symptoms in postmenopausal women, without estrogenic activity. This is potentially relevant for women who cannot use HRT, but the evidence base is small and physician involvement is appropriate.
Dosing ranges from the clinical trials {#dosing-from-trials}
All dosing framing here is derived from the published RCT protocols. This is not a prescribing recommendation.
Across the relevant trials: Gonzales 2002 used 1,500mg or 3,000mg/day for 12 weeks; both Dording studies used 3g/day; Brooks 2008 used 3.5g/day. The Stone 2009 cycling trial used approximately 20g/day — food-level intake rather than typical supplement dosing.
The most common RCT dose range is 1.5 to 3.5g/day of dried maca root powder for 8 to 12 weeks. Most positive effects were not observed until 6 to 8 weeks of consistent use.
Form considerations: Gelatinized maca (heated/extruded to break down starch and reduce glucosinolate content) is more bioavailable than raw powder and is the preferred form for anyone with any thyroid concern. It is also easier to digest. Most reputable supplement brands now offer gelatinized forms.
Timing: No RCT has established a clear timing advantage. Most participants in the trials took maca with meals. There is no published evidence for cycling protocols specific to maca.
Side effects and drug interactions {#side-effects-interactions}
Reported adverse effects from clinical trials
Maca has a favorable tolerability profile. The Gonzales 2002, Dording 2008, and Dording 2015 trials all reported adverse event rates comparable to placebo, with no serious adverse events attributed to maca. The most commonly noted minor effects are GI discomfort at higher doses and, occasionally, increased energy that interferes with sleep if taken in the evening.
Drug interactions
SSRIs (additive sexual function benefit, not interaction risk in the negative sense): As the Dording trials show, maca may augment sexual function recovery in SSRI users. This is potentially beneficial but still warrants prescriber awareness — not because maca and SSRIs interact pharmacokinetically in a harmful way, but because the combination is affecting the same symptom domain, and your prescriber should know all supplements you are taking.
Thyroid medications (levothyroxine, liothyronine, natural desiccated thyroid): Raw maca's glucosinolate content creates a potential goitrogen effect — meaning it may interfere with thyroid hormone synthesis and, in theory, reduce the effectiveness of thyroid replacement. The NCCIH maca information page and Memorial Sloan Kettering's integrative herbs database both flag this risk. Using gelatinized maca substantially reduces glucosinolate content and mitigates — though does not eliminate — this concern. Anyone on thyroid medication should discuss maca supplementation with their prescriber before starting.
Anti-androgens (bicalutamide, enzalutamide, finasteride, spironolactone): Maca does not directly oppose these drugs, since it does not raise androgens. However, red maca's studied effects on prostate tissue mean that anyone on active prostate-cancer treatment or anti-androgen therapy should disclose it to their oncologist or urologist.
Anticoagulants (warfarin): No published evidence of direct pharmacokinetic interaction. As a crucifer-family plant, maca contains vitamin K — not a concern at supplement doses for most people, but individuals on warfarin monitoring INR should flag any new supplement to their anticoagulation clinic.
Pregnancy and breastfeeding
No adequate safety data exists for maca at supplement doses during pregnancy or breastfeeding. Avoid until data exists. The risk-benefit calculus strongly favors caution.
Product picks {#product-picks}
For a use-case article like this one, the most relevant buying criteria are: confirmed gelatinized form (for goitrogen reduction and bioavailability), transparent sourcing from Andean growing regions, and no proprietary blending that obscures maca dose.
Top pick: Navitas Organics Maca Powder. Sources from Peru, offers gelatinized powder, third-party certified, widely available. Skip if you need capsules for precise dosing — powder requires self-measuring.
Best capsule option: Gaia Herbs Maca Root. Gaia has its own herb-traceability program; customers can trace their lot to the growing source. Capsule format suits clinical-trial-adjacent dosing (500 to 600mg per capsule). Skip if you prefer adding maca to food.
Budget pick: Now Foods Maca 750mg. NOW has consistent third-party testing documentation. The 750mg capsule reaches the lower Dording trial dose with four capsules per day. Verify the SKU — NOW sells both raw and gelatinized; confirm you're getting the gelatinized form.
An adaptogen brand can have impressive marketing and still miss third-party testing for the active marker compound. Maca is a particularly common category for underdosed products sold as "blends," where maca appears third or fourth in a proprietary stack at an undisclosed and likely small dose. Always confirm that the product you're buying contains a maca dose consistent with what the clinical trials used — not a token amount in a green-powder blend.
As an Amazon Associate, I earn from qualifying purchases. Product recommendations are based on real reviews and independent research.
Frequently asked questions {#faq}
Does maca actually increase testosterone?
No. Multiple trials — including Gonzales 2002 and both Dording studies — measured serum testosterone and found no significant change. Maca's observed effects on sexual desire and energy operate through pathways other than androgen elevation. If low testosterone is your concern, get it tested and address it with your physician directly.
How long does maca take to work?
Most positive effects in the clinical trials appeared at 6 to 8 weeks. If you see no change at 10 to 12 weeks of consistent use at an appropriate dose, maca is unlikely to work for you.
Is gelatinized maca better than raw?
For most users, yes. Gelatinized maca has been heat-processed to reduce glucosinolate content, which improves GI tolerability and reduces goitrogen exposure. The bioactive macamides survive the process. For anyone on thyroid medication, gelatinized is strongly preferable.
Can women take maca?
Yes. The Brooks 2008 trial was conducted entirely in postmenopausal women, and Dording 2015 was 67% female. Maca does not appear to have estrogenic activity — relevant for women who cannot use estrogen supplementation. Concerns (thyroid medication interaction, pregnancy avoidance) are the same for men and women.
What color variety is best for energy and libido?
Yellow maca or mixed maca matches what the human energy and libido trials used. Red has more evidence for prostate health and bone density; black has a small signal for sperm motility. For the specific RCT use cases in this article, yellow or unspecified mixed maca is the appropriate default.
Can I take maca with my antidepressant?
This warrants a conversation with your prescriber. The Dording trials were specifically in SSRI users and found benefit. Maca does not appear to cause serotonin syndrome or pharmacokinetic interaction with SSRIs, but your prescriber should know every supplement you take.
Conclusion: the bottom line on maca for energy and libido {#conclusion}
Maca is a real food with a modest but real human trial record. The honest version of its evidence is narrower than the supplement-category marketing suggests: the most consistent positive data is in SSRI-induced sexual dysfunction, where two controlled trials (Dording 2008 and Dording 2015) both found benefit with 3g/day for 8 to 12 weeks. In healthy adults, the signal for energy and libido is present but smaller, inconsistently replicated, and based on modest sample sizes.
What maca is not: a hormone booster. Testosterone and estrogen do not change meaningfully in the trials. If you are looking for a supplement that changes your hormonal profile, the maca trial record does not support that expectation.
For context on where maca's evidence sits relative to other adaptogens, the complete adaptogens guide covers which have RCT support versus which are running on traditional use and marketing. For ashwagandha's track record in the testosterone and stress space, see Ashwagandha for Testosterone: What the Clinical Trials Actually Show. If cortisol management is the underlying goal, Best Adaptogens for Cortisol ranks the evidence for the stress-axis adaptogens.
Next steps:
- If you are on an SSRI and experiencing sexual side effects: bring the Dording 2015 study to your prescriber
- If you are on thyroid medication: choose gelatinized maca only, and flag it with your prescriber
- If your goal is energy and no obvious cause has been addressed: check sleep, iron, and thyroid first; if those are clear, a 12-week maca trial at 1.5 to 3g/day is reasonable
- If you are pregnant or breastfeeding: avoid supplement-dose maca
Related reading
- A Complete Guide to Adaptogens: How They Work, What the Research Shows, and How to Choose
- Ashwagandha for Testosterone: What the Clinical Trials Actually Show
- Best Adaptogens for Cortisol: Ranking the Evidence in 2026
This article is for informational purposes and not medical advice. Maca root can interact with thyroid medications due to glucosinolate content (use gelatinized form if on any thyroid medication), may affect outcomes in patients on anti-androgen therapy, and has not been established as safe during pregnancy or breastfeeding. If you are on SSRIs or any prescription medication, consult your prescribing physician before adding any supplement. This article does not constitute medical advice for any individual situation.
As an Amazon Associate, I earn from qualifying purchases. Product recommendations are based on real reviews and independent research.
This article is for informational purposes and not medical advice. Herbal adaptogens, even traditional ones, can interact with thyroid medication, antidepressants, anticoagulants, immunosuppressants, blood-pressure drugs, and more. Consult a licensed physician before starting any adaptogen, particularly if you are pregnant, nursing, taking prescription medications, or managing a chronic condition.
